Stay updated on Neo-PV-01 + Nivolumab in Cancer Clinical Trial
Sign up to get notified when there's something new on the Neo-PV-01 + Nivolumab in Cancer Clinical Trial page.

Latest updates to the Neo-PV-01 + Nivolumab in Cancer Clinical Trial page
- Check3 days agoChange DetectedThe study record for NCT02897765 is now displayed, including its completed status, eligibility criteria, locations, treatment plan, and outcome measures for the NEO-PV-01 cancer vaccine trial.SummaryDifference63%

- Check10 days agoChange DetectedThe footer revision changed from v3.7.2 to v3.8.0; the page still shows a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedA general NIH notice about the transition from “Artificial Intelligence” to “Super Intelligence” appears above the page content, and the site revision number changes from v3.7.1 to v3.7.2. The study page itself continues to show a 403 error.SummaryDifference1%

- Check38 days agoChange DetectedThe ClinicalTrials.gov footer revision identifier was updated from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check52 days agoChange DetectedThe study page now displays a 403 Forbidden error instead of the full study record, with a simple header and a Home link. This replaces the previously visible study details and navigation, effectively locking access to the trial information on this page.SummaryDifference20%

- Check59 days agoChange DetectedRevision tag updated from v3.6.6 to v3.7.0 on the page, signaling a new version of the page content or metadata. This appears to be a maintenance update and does not alter the study information shown.SummaryDifference0.0%

Stay in the know with updates to Neo-PV-01 + Nivolumab in Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Neo-PV-01 + Nivolumab in Cancer Clinical Trial page.